NovaBay Total Stockholder Equity vs Non Current Assets Total Analysis

NBY Stock  USD 0.53  0.06  10.17%   
NovaBay Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating NovaBay Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NovaBay Pharmaceuticals is a good investment. Please check the relationship between NovaBay Pharmaceuticals Total Stockholder Equity and its Non Current Assets Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.

Total Stockholder Equity vs Non Current Assets Total

Total Stockholder Equity vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NovaBay Pharmaceuticals Total Stockholder Equity account and Non Current Assets Total. At this time, the significance of the direction appears to have weak relationship.
The correlation between NovaBay Pharmaceuticals' Total Stockholder Equity and Non Current Assets Total is 0.34. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of NovaBay Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of NovaBay Pharmaceuticals' Total Stockholder Equity and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of NovaBay Pharmaceuticals are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Total Stockholder Equity i.e., NovaBay Pharmaceuticals' Total Stockholder Equity and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.34
Relationship DirectionPositive 
Relationship StrengthVery Weak

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from NovaBay Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NovaBay Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.Selling General Administrative is likely to rise to about 7.5 M in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit5.6M7.8M7.9M8.1M
Total Revenue8.4M14.4M14.7M10.0M

NovaBay Pharmaceuticals fundamental ratios Correlations

0.83-0.37-0.190.330.450.150.170.33-0.61-0.25-0.160.730.640.630.50.60.370.870.590.30.23-0.110.12-0.190.0
0.83-0.11-0.340.15-0.110.0-0.20.28-0.76-0.04-0.40.790.340.740.540.530.290.880.620.330.20.06-0.21-0.29-0.18
-0.37-0.110.080.06-0.49-0.44-0.45-0.230.25-0.09-0.56-0.31-0.02-0.38-0.33-0.41-0.15-0.39-0.3-0.180.380.550.07-0.07-0.43
-0.19-0.340.080.280.220.090.62-0.060.3-0.26-0.32-0.25-0.17-0.31-0.33-0.53-0.14-0.16-0.3-0.41-0.40.35-0.160.880.07
0.330.150.060.280.350.090.60.360.17-0.90.05-0.050.48-0.250.390.230.520.070.260.260.47-0.05-0.210.270.01
0.45-0.11-0.490.220.350.260.630.120.06-0.340.370.050.6-0.030.050.230.20.160.1-0.060.03-0.290.570.150.24
0.150.0-0.440.090.090.260.48-0.27-0.35-0.060.290.37-0.350.28-0.10.1-0.360.34-0.15-0.16-0.28-0.33-0.280.20.03
0.17-0.2-0.450.620.60.630.480.320.24-0.610.25-0.060.09-0.190.06-0.030.290.060.00.08-0.08-0.18-0.190.650.36
0.330.28-0.23-0.060.360.12-0.270.320.14-0.37-0.040.10.270.130.450.090.950.210.380.750.44-0.17-0.190.020.55
-0.61-0.760.250.30.170.06-0.350.240.14-0.390.22-0.910.0-0.93-0.35-0.430.21-0.86-0.490.190.270.160.080.240.17
-0.25-0.04-0.09-0.26-0.9-0.34-0.06-0.61-0.37-0.39-0.060.16-0.430.42-0.29-0.18-0.510.06-0.08-0.42-0.630.050.21-0.22-0.13
-0.16-0.4-0.56-0.320.050.370.290.25-0.040.22-0.06-0.240.05-0.230.180.410.03-0.290.140.09-0.04-0.650.13-0.220.23
0.730.79-0.31-0.25-0.050.050.37-0.060.1-0.910.16-0.240.050.920.450.430.00.910.490.01-0.04-0.32-0.13-0.250.13
0.640.34-0.02-0.170.480.6-0.350.090.270.0-0.430.050.05-0.030.340.480.490.210.460.230.490.020.57-0.29-0.11
0.630.74-0.38-0.31-0.25-0.030.28-0.190.13-0.930.42-0.230.92-0.030.370.330.00.890.45-0.01-0.22-0.27-0.08-0.250.11
0.50.54-0.33-0.330.390.05-0.10.060.45-0.35-0.290.180.450.340.370.780.520.420.760.420.33-0.48-0.25-0.30.33
0.60.53-0.41-0.530.230.230.1-0.030.09-0.43-0.180.410.430.480.330.780.20.450.750.30.24-0.410.0-0.49-0.04
0.370.29-0.15-0.140.520.2-0.360.290.950.21-0.510.030.00.490.00.520.20.150.40.780.59-0.12-0.07-0.050.41
0.870.88-0.39-0.160.070.160.340.060.21-0.860.06-0.290.910.210.890.420.450.150.510.15-0.07-0.1-0.14-0.08-0.02
0.590.62-0.3-0.30.260.1-0.150.00.38-0.49-0.080.140.490.460.450.760.750.40.510.190.09-0.28-0.08-0.310.05
0.30.33-0.18-0.410.26-0.06-0.160.080.750.19-0.420.090.010.23-0.010.420.30.780.150.190.64-0.08-0.28-0.220.26
0.230.20.38-0.40.470.03-0.28-0.080.440.27-0.63-0.04-0.040.49-0.220.330.240.59-0.070.090.64-0.110.09-0.460.14
-0.110.060.550.35-0.05-0.29-0.33-0.18-0.170.160.05-0.65-0.320.02-0.27-0.48-0.41-0.12-0.1-0.28-0.08-0.11-0.010.41-0.69
0.12-0.210.07-0.16-0.210.57-0.28-0.19-0.190.080.210.13-0.130.57-0.08-0.250.0-0.07-0.14-0.08-0.280.09-0.01-0.3-0.06
-0.19-0.29-0.070.880.270.150.20.650.020.24-0.22-0.22-0.25-0.29-0.25-0.3-0.49-0.05-0.08-0.31-0.22-0.460.41-0.3-0.03
0.0-0.18-0.430.070.010.240.030.360.550.17-0.130.230.13-0.110.110.33-0.040.41-0.020.050.260.14-0.69-0.06-0.03
Click cells to compare fundamentals

NovaBay Pharmaceuticals Account Relationship Matchups

NovaBay Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets11.2M15.2M24.0M16.4M9.0M14.4M
Total Stockholder Equity973K12.3M10.2M10.6M3.3M5.3M
Other Assets477K912K476K489K562.4K461.6K
Common Stock Shares Outstanding618.3K28.6K35.6K46K120.4K125.5K
Liabilities And Stockholders Equity11.2M15.2M24.0M16.4M9.0M14.4M
Other Stockholder Equity125.7M148.0M150.9M165.1M176.1M88.1M
Total Liab10.2M2.9M13.8M5.8M5.7M7.1M
Other Current Liab993K1.7M763K667K1.0M1.3M
Total Current Liabilities5.7M2.8M3.4M4.3M4.3M4.1M
Property Plant And Equipment Net1.4M520K604K2.0M1.4M1.0M
Net Debt(2.9M)(11.4M)(7.0M)(3.3M)(390K)(409.5K)
Retained Earnings(125.0M)(136.1M)(141.9M)(158.2M)(174.8M)(166.1M)
Accounts Payable331K302K1.0M1.1M1.1M812.7K
Cash6.9M12.0M7.5M5.4M3.1M6.0M
Non Current Assets Total1.8M996K10.8M5.1M1.9M2.0M
Cash And Short Term Investments6.9M12.0M7.5M5.4M3.1M3.0M
Common Stock Total Equity154K171K279K418K480.7K263.6K
Other Current Assets105K576K778K560K388K463.4K
Property Plant And Equipment Gross1.4M520K1.2M2.6M2.1M1.1M
Total Current Assets9.4M14.2M13.2M11.3M7.2M9.5M
Accumulated Other Comprehensive Income(243K)(509K)(560K)(275K)(247.5K)(259.9K)
Common Stock279K418K478K652K112K106.4K
Property Plant Equipment110K520K604K2.0M1.8M1.8M
Other Liab2.5M560K4.1M10.1M11.6M12.2M
Current Deferred Revenue822K730K1.3M1.8M946K1.2M
Non Current Liabilities Total4.6M87K10.4M1.6M1.4M2.6M
Short Term Debt3.5M832K505K906K2.1M2.2M
Non Currrent Assets Other77K2K476K489K497K300.0K
Net Receivables1.1M1.1M1.7M2.0M759K721.1K
Net Tangible Assets5.0M973K12.3M(237K)(213.3K)(202.6K)
Retained Earnings Total Equity(111.1M)(115.0M)(125.0M)(136.1M)(122.5M)(116.3M)
Capital Surpluse125.7M148.0M150.9M165.1M189.8M118.8M
Inventory492K608K3.2M3.4M2.9M3.0M
Non Current Liabilities Other198K4.6M561K334K300.6K285.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NovaBay Stock Analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.